Mimio Health
Latest round
- Seed
Last raised
- Mar 2023
Total raised
- $2.5M
Investors
- 6
About Mimio Health
Based in California, US, and founded in 2022, Mimio Health, Inc. operates as a pharmaceutical company that engages in selling alternative food supplements. In March 2023, Mimio Health, Inc. Mimio is a biomimetic supplement that activates your biology to support optimized metabolism and energy, reduced appetite and cravings, improved mood and cognition, enhanced performance and recovery, and healthy aging. Mimio was designed from fasting research to help you unlock the benefits of fasting on demand. It uses a unique combination of clinically-validated fasting metabolites to help activate your cells’ natural ability to clean, repair, and protect themselves.
Who invested in Mimio Health
6 investors across 1 round
See all investors in Mimio Health
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 15, 2023
Amount
$2.5M
Investors
Questions about Mimio Health
Who invested in Mimio Health?
Mimio Health has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mimio Health raised?
Mimio Health has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Mimio Health last raise money?
Mimio Health's most recent round on record is a Seed, in Mar 2023.
What does Mimio Health do?
Based in California, US, and founded in 2022, Mimio Health, Inc.
Where is Mimio Health headquartered?
Mimio Health is headquartered in San Francisco, US.
Which VCs invest in companies like Mimio Health?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Mimio Health's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Mimio Health? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.